Beisen, a Chinese supplier of HR evaluation and testing tools and services, has received $10 million in Series B funding from Matrix Partners and Sequoia Capital. It comes three years after the company’s first-round of financing, which saw Shenzhen Capital Group and Tianjin Venture Capital commit an undisclosed sum.
The new funding will be used for product development, with Beisen having introduced a cloud-based platform that offers integrated recruitment, evaluation and talent management services. According to CEO...
Even if pan-Asian buyout firms aren't actively pursuing investments in internet-related businesses, they cannot ignore the potential disruptive impact of these technologies on other portfolio companies
Mekong Capital's 6.3x return on its investment in Vietnam-based pharmaceuticals player Traphaco involved turning the company's distribution model on its head, as well as supporting expansion and improving governance
China Renaissance has added dedicated healthcare and mezzanine debt strategies to its existing growth-stage private equity offering as part of efforts to more than treble its assets under management (AUM) over the next three years.
China Venture Capital Fund, a VC vehicle backed by the Chinese government, and ChinaEquity Group have jointly led a RMB670 million ($101 million) round for 3D Medicines, which focuses on personalized diagnostics and treatment for cancer.